206 related articles for article (PubMed ID: 33797199)
1. Outcome of hypofractionated breast irradiation and intraoperative electron boost in early breast cancer: A randomized non-inferiority clinical trial.
Fadavi P; Nafissi N; Mahdavi SR; Jafarnejadi B; Javadinia SA
Cancer Rep (Hoboken); 2021 Oct; 4(5):e1376. PubMed ID: 33797199
[TBL] [Abstract][Full Text] [Related]
2. Toxicity and cosmetic outcome after hypofractionated whole breast irradiation and boost-IOERT in early stage breast cancer (HIOB): First results of a prospective multicenter trial (NCT01343459).
Fastner G; Reitsamer R; Urbański B; Kopp P; Murawa D; Adamczyk B; Karzcewska A; Milecki P; Hager E; Reiland J; Ciabattoni A; Matuschek C; Budach W; Nowell K; Schumacher C; Ricke A; Fusco V; Vidali C; Alessandro M; Ivaldi GB; Ziegler I; Fussl C; Zehentmayr F; Grambozov B; Sir A; Hitzl W; Ricardi U; Sedlmayer F
Radiother Oncol; 2020 May; 146():136-142. PubMed ID: 32151790
[TBL] [Abstract][Full Text] [Related]
3. IOERT versus external beam electrons for boost radiotherapy in stage I/II breast cancer: 10-year results of a phase III randomized study.
Ciabattoni A; Gregucci F; Fastner G; Cavuto S; Spera A; Drago S; Ziegler I; Mirri MA; Consorti R; Sedlmayer F
Breast Cancer Res; 2021 Apr; 23(1):46. PubMed ID: 33849606
[TBL] [Abstract][Full Text] [Related]
4. Hypofractionated Whole Breast Irradiation and Boost-IOERT in Early Stage Breast Cancer (HIOB): First Clinical Results of a Prospective Multicenter Trial (NCT01343459).
Fastner G; Reitsamer R; Gaisberger C; Hitzl W; Urbański B; Murawa D; Matuschek C; Budach W; Ciabattoni A; Reiland J; Molnar M; Vidali C; Schumacher C; Sedlmayer F; On Behalf Of The Hiob Trialist Group
Cancers (Basel); 2022 Mar; 14(6):. PubMed ID: 35326548
[TBL] [Abstract][Full Text] [Related]
5. Ten-year results of hypofractionated whole breast radiotherapy and intraoperative electron boost in premenopausal women.
Leonardi MC; Cormio CF; Frassoni S; Dicuonzo S; Fodor C; Intra M; Zerella MA; Morra A; Cattani F; Comi S; Fusco N; Zaffaroni M; Galimberti V; Veronesi P; Dellapasqua S; De Lorenzi F; Ivaldi GB; Bagnardi V; Orecchia R; Rojas DP; Jereczek-Fossa BA
Radiother Oncol; 2022 Dec; 177():71-80. PubMed ID: 36377094
[TBL] [Abstract][Full Text] [Related]
6. Preliminary Results of a Randomized Study on Postmenopausal Women With Early Stage Breast Cancer: Adjuvant Hypofractionated Whole Breast Irradiation Versus Accelerated Partial Breast Irradiation (HYPAB Trial).
Franceschini D; Loi M; Chiola I; Arculeo S; Marzo M; Fernandes B; Masci G; Torrisi R; Tinterri C; Testori A; Santoro A; Scorsetti M
Clin Breast Cancer; 2021 Jun; 21(3):231-238. PubMed ID: 33121891
[TBL] [Abstract][Full Text] [Related]
7. Hypofractionated whole breast irradiation after IORT treatment is safe in patients receiving adjuvant chemotherapy.
Burgos-Burgos J; Vega V; Macias-Verde D; Gómez V; Travieso-Aja M; Travieso J; Vicente E; Murias C; Santana C; Ospina J; Lara PC
Clin Transl Oncol; 2021 Dec; 23(12):2579-2583. PubMed ID: 34091868
[TBL] [Abstract][Full Text] [Related]
8. Chronic toxicity and long-term outcome in intraoperative electron radiotherapy as boost followed by whole-breast irradiation.
Oses G; Cases C; Valduvieco I; Farrús B; Alonso I; Caparrós X; Mases J; Muñoz-Guglielmetti D; Biete A; Castro C; Escudero E; Molina M; Herreros A; Saez J; Mollà M
Clin Transl Oncol; 2021 Aug; 23(8):1593-1600. PubMed ID: 33534078
[TBL] [Abstract][Full Text] [Related]
9. Fatigue following radiotherapy of low-risk early breast cancer - a randomized controlled trial of intraoperative electron radiotherapy versus standard hypofractionated whole-breast radiotherapy: the COSMOPOLITAN trial (NCT03838419).
Forster T; Jäkel C; Akbaba S; Krug D; Krempien R; Uhl M; Häfner MF; König L; Koerber SA; Harrabi S; Bernhardt D; Behnisch R; Krisam J; Hennigs A; Sohn C; Heil J; Debus J; Hörner-Rieber J
Radiat Oncol; 2020 Jun; 15(1):134. PubMed ID: 32487184
[TBL] [Abstract][Full Text] [Related]
10. Cost and Cost-Effectiveness of Image Guided Partial Breast Irradiation in Comparison to Hypofractionated Whole Breast Irradiation.
Shah C; Ward MC; Tendulkar RD; Cherian S; Vicini F; Singer ME
Int J Radiat Oncol Biol Phys; 2019 Feb; 103(2):397-402. PubMed ID: 30253236
[TBL] [Abstract][Full Text] [Related]
11. The Impact of Chemotherapy on Toxic Effects and Cosmetic Outcome in Patients Receiving Whole Breast Irradiation: An Analysis Within a Statewide Quality Consortium.
Dilworth JT; Griffith KA; Pierce LJ; Jagsi R; Quinn TJ; Walker EM; Radawski JD; Dominello MM; Gustafson GS; Moran JM; Hayman JA; Vicini FA
Int J Radiat Oncol Biol Phys; 2022 Jun; 113(2):266-277. PubMed ID: 35157997
[TBL] [Abstract][Full Text] [Related]
12. Analysis of Outcomes Using Hypofractionated Tumor Bed Boost Combined With Hypofractionated Whole Breast Irradiation for Early-stage Breast Cancer.
Yu E; Huang D; Leonard K; Dipetrillo T; Wazer D; Hepel J
Clin Breast Cancer; 2017 Dec; 17(8):638-643. PubMed ID: 28629952
[TBL] [Abstract][Full Text] [Related]
13. ESTRO IORT Task Force/ACROP recommendations for intraoperative radiation therapy with electrons (IOERT) in breast cancer.
Fastner G; Gaisberger C; Kaiser J; Scherer P; Ciabattoni A; Petoukhova A; Sperk E; Poortmans P; Calvo FA; Sedlmayer F; Leonardi MC
Radiother Oncol; 2020 Aug; 149():150-157. PubMed ID: 32413529
[TBL] [Abstract][Full Text] [Related]
14. IOERT as anticipated tumor bed boost during breast-conserving surgery after neoadjuvant chemotherapy in locally advanced breast cancer--results of a case series after 5-year follow-up.
Fastner G; Reitsamer R; Ziegler I; Zehentmayr F; Fussl C; Kopp P; Peintinger F; Greil R; Fischer T; Deutschmann H; Sedlmayer F
Int J Cancer; 2015 Mar; 136(5):1193-201. PubMed ID: 24995409
[TBL] [Abstract][Full Text] [Related]
15. Hypofractionated radiotherapy with simultaneous tumor bed boost (Hi-RISE) in breast cancer patients receiving upfront breast-conserving surgery: study protocol for a phase III randomized controlled trial.
Jin K; Luo J; Yu X; Guo X
Radiat Oncol; 2024 May; 19(1):62. PubMed ID: 38802888
[TBL] [Abstract][Full Text] [Related]
16. Comparison of two radiation boost schedules in postlumpectomy patients with breast cancer.
Yadav BS; Sharma SC; Singh G; Dahiya D
J Cancer Res Ther; 2020; 16(6):1344-1349. PubMed ID: 33342794
[TBL] [Abstract][Full Text] [Related]
17. HYPofractionated Adjuvant RadioTherapy in 1 versus 2 weeks in high-risk patients with breast cancer (HYPART): a non-inferiority, open-label, phase III randomised trial.
Yadav BS; Dahiya D; Kannan P; Goyal S; Laroiya I; Irrinki S; Singh NR; Sharma R
Trials; 2024 Jan; 25(1):21. PubMed ID: 38167339
[TBL] [Abstract][Full Text] [Related]
18. Hypofractionated Simultaneous Integrated Boost Radiotherapy Versus Conventional Fractionation Radiotherapy of Early Breast Cancer After Breast-Conserving Surgery: Clinical Observation and Analysis.
Dong J; Yang Y; Han D; Zhao Q; Liu C; Sun H; Wang Z; Lin H; Huang W
Technol Cancer Res Treat; 2021; 20():15330338211064719. PubMed ID: 34898315
[No Abstract] [Full Text] [Related]
19. Hypofractionated whole breast irradiation after IORT treatment: evaluation of acute toxicity and cosmesis.
Burgos-Burgos J; Vega V; Macias-Verde D; Gómez V; Travieso-Aja M; Travieso J; Vicente E; Santana C; Ospina J; Lara PC
Clin Transl Oncol; 2021 Jan; 23(1):179-182. PubMed ID: 32445034
[TBL] [Abstract][Full Text] [Related]
20. Acute Toxicity and Early Oncological Outcomes After Intraoperative Electron Radiotherapy (IOERT) as Boost Followed by Whole Breast Irradiation in 157 Early Stage Breast Cancer Patients-First Clinical Results From a Single Center.
König L; Lang K; Heil J; Golatta M; Major G; Krug D; Hörner-Rieber J; Häfner MF; Koerber SA; Harrabi S; Bostel T; Debus J; Uhl M
Front Oncol; 2019; 9():384. PubMed ID: 31165041
[No Abstract] [Full Text] [Related]
[Next] [New Search]
